Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5943199 | Atherosclerosis | 2016 | 8 Pages |
Abstract
In dyslipidaemic patients with high TG and low HDL-C, K-877 improved TG, HDL-C, and other lipid parameters without increasing AEs or ADRs, compared to placebo and fenofibrate. K-877 can be expected to improve atherogenicity and to be a new beneficial treatment for dyslipidaemic patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Shun Ishibashi, Shizuya Yamashita, Hidenori Arai, Eiichi Araki, Koutaro Yokote, Hideki Suganami, Jean-Charles Fruchart, Tatsuhiko Kodama, K-877-04 Study Group K-877-04 Study Group,